Additionally, mutations in the RNA-binding protein FUS are associated with elevated neuronal m6A levels, suggesting pathogenic interactions that can be mitigated by inhibiting METTL3 in ALS [76,133]. This evidence concerns the gene METTL3 and amyotrophic lateral sclerosis.